1. Contractors
  2. Roche Diabetes Care Inc

Roche Diabetes Care Inc

Federal contractor · In-Vitro Diagnostic Substance Manufacturing

Roche Diabetes Care has 10 federal contracts of $100,000 or more active since October 2023, with $4.29M obligated, from 1 agency. 2 are still running, 2 ending within 18 months.

Contracts
10 since FY2024$4,289,930 obligated, contracts of $100,000 or more
Running now
2 contracts1 ended in the last 12 months
Biggest customer
Indian Health Service$4.29M on 10 contracts
UEI
F6JDDN8L9JM4Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$667,707
FY2021$1,481,958
FY2023$739,785
FY2024$250,000
FY2025$900,480
FY2026$250,000

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Fy 25 Roche Diabetes Care Bpa - Medical SupplyIndian Health Service · 75H71025F80116$244,000Mar 31, 2027in 4 monthsIN
Bpa Call - Roche Diabetes Care, Supplies, Pimc, Materials Management, Pop: 09/27/2026 - 09/26/2027Indian Health Service · 75H71226F28008$250,000Sep 26, 2027in 10 monthsAZ

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Indian Health Service10 contracts$4,289,930

What they sell

IndustryAmount
In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 10 contracts$4,289,930

Where the work is

Place of workAmount
New Mexico3 contracts$2,688,318
Arizona4 contracts$857,612
Indiana3 contracts$744,000

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Indian Health Service: see the list.

Get new notices like Roche Diabetes Care's work

New contract opportunities under NAICS 325413, in-vitro diagnostic substance manufacturing, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy